Zuvest
← All research
Latest research ·

MU Micron Technology, Inc.

Technology · Semiconductors
$701.28
-1.56% on the day · price at time of report
Cautious
CautiousNeutralConstructive

Verdict by horizon

Long-term investing
Wait for a better price

The market thinks Micron's earnings are peak and deserve a single-digit multiple, while sell-side targets assume the boom persists. At $701, the price roughly equals my probability-weighted value (~$630), so there is no margin of safety yet. This is a hig

Swing trading
No valid setup

Either (a) a hold above 651 with tightening ranges and volume dry-up, then a close above EMA21 ~804 / resistance 823 as the pivot with the RS line turning up and SPY reclaiming its 50-day; or (b) a short-term bounce toward 752.77 (EMA10) or 823 failing as a sh

Day trading
Bias: no_trade (not in play)

Session is regular, 15:38 ET. RVOL 1.3 is below the 1.5 threshold, so the stock is not clearly in play. 26 VWAP crosses suggest a range or chop day (setup 11). Price is 701.33 vs VWAP 701.96, with LOD 687.34 and HOD 722.96 (67% of ADR used). SPY is below its 5

Options
No structure

Cheap to fair: ATM IV 75.5% at 30 DTE vs HV20 105.8% (IV/HV20 0.71), but HV60 is 72.5%, so it is fair against the longer window. The term structure is inverted (5 DTE 79.1%, 58 DTE 70.9%) and 25d put skew is steep (9.3 pts at 30 DTE). IV rank is unknown. The 3

Views by discipline

▤ Fundamentals & valuationneutral · 45
⌕ Accounting quality & eventsneutral · 55
◍ Macro, policy & creditbearish · 62
⟋ Technical analysisbearish · 72
⇄ Positioning & sentimentneutral · 55

Valuation snapshot

Fair value (bear / base / bull)$300.00 / $600.00 / $1,100.00
Street mean target$1,561.91
P/E fwd · FCF yield · ROIC3.4 · 7.43% · 84.7%

Micron Technology, Inc. engages in the provision of semiconductor memory and storage products in the United States, Taiwan, Mainland China, other Asia Pacific countries, Japan, Europe, and internationally. It operates through Cloud Memory Business Unit, Core Data Center Business Unit, Mobile and Client Business Unit, and Automotive and Embedded Business Unit segments. The company provides dynamic random access memory (DRAM) products, including High-Bandwidth Memory, doublie data rate, low-power

Charts

Price, indicators & swing plan

Intraday & day-trade plan

Research views

Valuation

Relative strength

Fundamentals

Options

Market backdrop

Research memo

MU (Micron Technology): Decision Memo, 2026-11-18

Education, not personalized financial advice. Every number below comes from the specialist reports or the facts block. Where data is missing, I say "unknown".

Bottom line

  • Long-term investing: WAIT. No position now. At $701.28 the stock trades roughly 10% above the Fundamental analyst's probability-weighted value of about $630. That leaves no margin of safety. The cheap-looking multiples (trailing P/E 9.4, forward P/E 3.4) probably reflect peak-cycle profits, not a bargain. The analyst's patience zone is $350–500.
  • Swing trading: NO TRADE. The chart is in a medium- and short-term downtrend. It passes only 4 of 8 Trend Template checks and sits in Weinstein Stage 1/3. There is no valid long setup. A short on a failed bounce is conceptually possible, but the stock's daily swings are too wide for a $50 risk budget.
  • Day trading: NO TRADE. the risk review rejected the only proposal, a next-session VWAP rejection short. Its reward-to-risk was 1.0 against a 1.5 minimum, and the stock is not "in play" (RVOL 1.3). Today's session is nearly over.
  • Options: NO TRADE. the risk review rejected the bear put spread. Its $465 maximum loss is far above the $100 options budget, and a budget override is not approved.
  • Single most important risk: memory profits are at a cyclical extreme. Gross margin is 80.7%, versus −9.1% in FY2023. If the cycle turns, earnings could fall by a large multiple. The first hard test is earnings on 2026-12-23. For traders, the same risk shows up as gap risk: ATR (average true range, the typical daily move) is 8.21% of price, and the worst earnings move was −16.18%.

Long-term investment view

Stance: Neutral. Wait for price or evidence. The investing horizon rests mainly on fundamentals, forensic accounting and macro. None of these three lenses is bullish at today's price.

1. Is it a great business right now? Yes, but at a cyclical peak. - FY2026 revenue was $133.2B, up 256% from $37.4B. - Gross margin is 80.7% and operating margin is 74.6%. - ROIC (return on invested capital) is 84.7% against a WACC (the company's cost of capital) of 13.0%. That means it currently creates a great deal of value. - The history matters, though. FY2023 operating margin was −34.8% and FY2024 was 5.2%. A durable moat normally needs high returns sustained across a full cycle, and this record does not show that yet. - This is the classic base-rate question: how often do memory makers hold peak margins? The specialists did not supply a base rate, so it is unknown. The history above suggests it is low.

2. Is the balance sheet safe? Very. - Net cash is about $38.3B (cash $43.4B, debt $5.2B). - Altman Z-score is 11.97, well inside the "safe" zone. Piotroski F-Score is a perfect 9/9. - Free cash flow (FCF) was $58.96B, a 7.43% FCF yield. - Bankruptcy risk is not the issue. Earnings risk is.

3. What is priced in? - A forward P/E of 3.4 against a next-quarter EPS estimate of $38.29 tells you the market does not believe current earnings will last. That is the "peak-earnings trap" logic. - The 45 sell-side analysts disagree with the market. Their rating is strong_buy, with a mean target of $1,562 (+123%). - The Fundamental analyst sits in between. A normalized-earnings model, which assumes mid-cycle FCF of roughly 25–40% of peak, gives:

Scenario Value Probability
Bear $300 ~30%
Base $600 ~45%
Bull $1,100 ~25%
Expected value ≈ $630
  • For comparison, the mechanical DCF (discounted cash flow model) range is $707 / $1,209 / $1,659. It starts from peak FCF, so I give it little weight. Note that even its bear case sits right at today's price.

4. Forensic check: WATCH, not RED FLAG. - The Beneish M-Score, a screen for possible earnings manipulation, is −0.15. That is above the −1.78 warning line. - However, the score is driven almost entirely by sales growth (SGI 3.563). Accruals are negative (TATA −0.024), which means profits are backed by cash. - Two items deserve follow-up: - Receivables grew 343.85% versus revenue growth of 256.33%. - There were two 8-K Item 5.02 officer changes, plus insider selling of $246.3M with zero insider buys.

5. Macro: HEADWIND. - The 10-year yield is 5.07% and CPI inflation is 4.08%. - Tech (XLK) trails SPY by 6.59 points over 3 months. - MU's beta is 2.4–3.43, meaning it typically moves 2–3x the market. A 5% SPY drop implies roughly −12% to −17% for MU.

Thesis in one sentence: "The market prices Micron as a peak-cycle earner and the sell-side prices a lasting boom. We think the truth is near $630 on probability, so we wait for either a lower price or proof that through-cycle margins are structurally higher."

What would make us bullish: - Evidence that long-term supply agreements or HBM (high-bandwidth memory) contracts keep gross margin above 60% through a downturn. - Price moving into the $350–500 zone, which would create a real margin of safety.

Thesis breakers to write down now, before owning any shares: - Gross margin below about 60% for two straight quarters while DRAM/NAND contract prices fall. - Supply-chain inventory builds or competitor capacity additions. - Hyperscaler capex cuts. - FCF conversion below 50%.

Key unknowns: DRAM/NAND pricing, inventory days, book-to-bill, HBM contract terms, peer multiples. These are the branches of the issue tree that matter most. They are also exactly the ones we lack data on.

Swing trading view

Stance: Bearish bias, but NO TRADE. The swing horizon rests mainly on technicals, flow and the macro regime. The first two lean bearish to neutral, and the third is a headwind.

Trend: - Price is below every key average: - 10-day EMA: 752.77 - 21-day EMA: 803.92 - 200-day SMA: 769.72 - 150-day SMA: 891.41 - 50-day SMA: 925.46 - ADX of 35.5, with −DI at 36.4 versus +DI at 15.0, confirms a strong downtrend. - The base is getting looser, not tighter. Pullback depths went 22% → 29% → 52%. That is the opposite of a constructive base.

Counter-evidence (be honest about it): - The 200-day SMA is still rising, the 1-year return is +190%, and Mansfield relative strength is 3.99. The long-term uptrend is not yet broken. - RSI2, a 2-day oversold gauge, is 8.8. That flags a possible sharp bounce toward 752.77 or 820–823. - The classic RSI2 buy rule requires price above the 200-day SMA, and price is 8.89% below it. So this is not a valid long signal. It is a warning to anyone short.

Flow: - Short interest is only 2.07% of float. There is no squeeze fuel, and shorts are not driving the decline. - Tape-level volume shows mild distribution: CMF20 is −0.128 and OBV is falling. - The 13F data showing institutions adding is about 45 days stale. It predates the recent drop.

The structural problem is sizing. - A sensible swing stop of 1.5–2x ATR is 86–115 points. - A $50 risk budget therefore allows less than one share. - Even with a perfect setup, the stock's volatility is mismatched to this account's risk rules. the risk review also says the regime calls for reduced risk of 0.25–0.5% at most.

What would create a swing trade later (two paths): - (a) Long path: 1. Price holds above 650–651 with tightening ranges and drying volume. 2. Then it closes above the 21-day EMA (~804) and the 823 resistance level. 3. The RS line turns up. 4. SPY reclaims its 50-day average. - (b) Short path (shorts are allowed): a bounce toward 752.77 or 823 fails. This still needs a defined-risk vehicle that fits the budget and has risk review approval.

Trend-following system: Donchian 20/55 is flat. A close below 650 would flip it to a short signal. Note that 651 support is only about 7% below the close, which is less than one ATR away.

Earnings rule: do not hold any swing position through 2026-12-23.

Day trading view (today / next session)

Stance: NO TRADE. The risk review's rejection is final.

Today: - It is about 15:38 ET, with roughly 20 minutes left. The flat-by-close rule applies. - RVOL (relative volume, today's volume versus normal) is 1.3, below the 1.5 "in play" threshold. - Price crossed VWAP (the volume-weighted average price) 26 times. That signals a choppy range day, not a trend day.

Next session: the proposed VWAP-rejection short was rejected for three reasons: 1. Reward-to-risk to the first target was only 1.0, below the 1.5 minimum. 2. The stock was not in play. 3. The account is a $10k margin account under the U.S. pattern-day-trader (PDT) rule. Four or more day trades in five business days triggers restrictions, so each day trade is scarce. A marginal setup should not use one.

What a valid re-submission would need: - A first target worth at least 1.5R. "R" is the amount risked, here $50. - Confirmed RVOL of 1.5 or higher.

Reference levels if you are only watching: - VWAP: 701.96 - Low of day: 687.34 - Previous-day low: 666.88 - High of day: 722.96

Options view

Stance: NO TRADE. The bear put spread is rejected.

Volatility picture: - At-the-money implied volatility (IV) for 30 days is 75.5%. Recent realized volatility (HV20) is 105.8%, so options look cheap versus the last month (ratio 0.71). Against the 60-day realized volatility of 72.5%, they look fair. - The term structure is inverted: 5-day IV is 79.1% versus 70.9% at 58 days. That signals near-term fear or event pricing. - Put skew is steep, 9.3 points at 30 days. Traders are paying up for downside protection. - The options market expects about ±17.5% (±$122.7) over 30 days and about ±8.1% (roughly 644–758) over 5 days. - IV rank is unknown.

Why the spread fails: - Its maximum loss of $465 is more than four times the $100 options budget and about nine times the $50 1R. - The structure was otherwise sensible. It was defined-risk, it expired before earnings (no IV crush), and it bought premium when IV was below realized volatility. - On a $10k account, MU's option prices are simply too large for the risk rules. - All other structures were also ruled out. They were either far over budget, required naked or large cash commitments, or used thin weekly options (median open interest of 60).

Lesson: a good idea is not the same as a good trade for your account.

Where the analysts disagree

1. Fair value: sell-side vs. fundamental vs. market. - Analyst targets: $1,562. Mechanical DCF base case: $1,209. Normalized value: about $630. Price: $701. - Stronger evidence: the normalized approach. For a cyclical business with FY2023 operating margin at −34.8%, extrapolating 80% gross margins is the bigger error risk. - The uniformly bullish sell-side also means there is little variant perception in being bullish. Variant perception means holding a well-founded view that differs from the consensus.

2. Institutions vs. insiders vs. the tape. - 13F filings show 8 of the top 10 holders adding. - Insiders sold $246.3M with zero buys, and the tape shows distribution. - Stronger evidence: the tape and insider data are more recent. 13F data lags about 45 days. Insider selling alone is a weak signal.

3. Long-term trend up vs. short- and medium-term trend down. - The rising 200-day SMA and +190% 1-year return conflict with price below all short-term averages. - Resolution by horizon: for swing and day trading the down-trend dominates. For investing, the long-term trend is less relevant than valuation.

4. Bearish trend vs. oversold bounce risk. - The Technical and Options specialists leaned short. RSI2 of 8.8 and the risk review both flag a violent bounce as a real threat to shorts. - Resolution: the risk review's verdict is final. No short.

5. Forensic flags vs. growth artifact. - The Beneish score and accruals ratio flag "investigate". The specialist judged them mostly a byproduct of hypergrowth and capex. - Status: unresolved until the receivables and DSO data arrive.

6. Data conflict on beta (2.4 vs. 3.43). - This is likely due to different measurement windows. - Either way, MU moves well over twice the market.

What to watch next (catalysts, levels, data)

Earnings, 2026-12-23 (EPS estimate $38.29, revenue estimate $61.83B): - The key line is gross margin, judged against the 60% thesis-break line. - Watch guidance and inventory commentary. - The last earnings beat was only 1.36%, so beats are shrinking. The average earnings-day move is 7.6%.

Price levels: - 650–651 support. A high-volume close below it opens a path toward 435.76 and flips the Donchian system short. - 752.77, the 10-day EMA. This is the first bounce test. - 804 / 820–823, the 21-day EMA and Kijun resistance. A reclaim would neutralize the bearish view.

Macro triggers: - SPY versus its 50-day and 200-day averages. It is only 0.07% above the 200-day. - VIX versus VIX3M (backwardation persisting, or VIX above 30). - The 10-year yield closing above about 5.2%. - The high-yield credit spread moving from 3.43 toward 4.5 percentage points. - A CPI reading above 4.5%.

Forensic follow-ups: - Sizes of the Form 144 filings and whether they are under 10b5-1 plans. - Who left in the 8-K 5.02 changes, especially whether finance leadership was affected. - Receivables footnote and DSO trend. - Any 8-K Item 4.01 or 4.02 filing (auditor change or restatement), which would escalate to a red flag.

Industry data (currently unknown): - DRAM/NAND contract pricing. - Competitor capacity additions. - Hyperscaler capex plans.

Sentiment flips: - Cluster insider buying by several distinct insiders (bullish). - Large top-holder reductions in the next 13F (bearish).

Risk-checked trade plans

Trade plans are illustrative and were risk-checked against a reference $10,000 model portfolio (0.5% risk per trade); any share counts refer to that model portfolio.

dayVWAP rejection short (only for the next session, if the open is weak and it is the trader's one allowed day trade)shortrejected
Entry699.00
Stop708.00
Targets690.00, 687.34
Reward : risk1.00

Risk review: Hard violation: reward:risk to first target is 1.00 vs the 1.5 minimum. Sizing gives 3 shares ($27 risk, $2,097 position = 21% of the account, capped by the max position rule), so the payoff is trivial against the slippage risk from a wide ATR of 57.56. The account is under $25k on margin, so day trades are scarce and should not go to a marginal setup. RVOL is 1.3, below 1.5, and there are 26 VWAP crosses (chop). Beta 2.4, VIX in backwardation and 8 distribution days add gap and whipsaw risk. A re-submission would need a first target giving at least 1.5R, which means a wider target or a tighter stop, plus confirmed RVOL of 1.5 or more.

optionsBear put debit spread 700/690, Dec 18 expiryrejected
Legsbuy put 700.00 · sell put 690.00
Expiry2026-12-18
Max loss / contract$465

Risk review: Hard violation: max loss $465 per contract exceeds the $100 options budget (contracts_allowed = 0). The options analyst also says it does not fit the profile. The loss is 4.65% of the account, about 9x the $50 1R. The spread is only $10 wide against a ±$122.7 expected move, and the breakeven is 695.35, only about 0.85% below the current price of 701.28. RSI2 of 8.8 means a violent bounce toward 752-823 could produce the max loss. I will not approve a budget override.

Analysis by discipline

▤Fundamentals & valuation neutral · 45

Micron is at the extreme peak of a memory upcycle: FY2026 revenue of $133B (+256%) with an 80.7% gross margin and 74.6% operating margin. The stock looks very cheap on trailing earnings (P/E 9.4, EV/EBITDA 7.0), but memory earnings are historically cyclical and these multiples are probably capitalizing peak profits. The mechanical DCF extrapolates peak FCF and likely overstates value, so I treat it with heavy skepticism. The price has already fallen 44% from its high, and the market appears to be pricing a cycle turn.

Key findings

  • Growth and margins are at cycle-peak levels, not a steady state Revenue $133.2B vs $37.4B prior year (+256%); gross margin 80.7% vs 39.8% a year ago and -9.1% in FY2023; latest quarter revenue +379% yoy. The playbook flags cycle position and gross-margin trend as the key KPIs.
  • Exceptional returns on capital, but cyclical rather than proven through-cycle ROIC 84.7% vs WACC 13.0%; ROE 61.4%. FY2023 operating margin was -34.8% and FY2024 was 5.2%. A moat needs ROIC above 15% sustained for 10+ years, which this history does not show.
  • Cash generation is strong and the balance sheet is a fortress FCF $58.96B (69% conversion, FCF yield 7.43%); cash $43.4B vs debt $5.2B (net debt -$38.3B); interest coverage 941x; current ratio 3.31; SBC 1.0% of revenue; diluted shares 1,143m vs 1,093m in FY2023 (about 4.6% dilution over 3 years).
  • Multiples look optically cheap, which is the classic peak-earnings trap P/E trailing 9.4, forward 3.4, PEG 0.16, EV/EBITDA 7.0, P/B 5.73. A forward P/E of 3.4 implies the market does not believe consensus EPS (next quarter est. $38.29) is sustainable.
  • The mechanical DCF is highly sensitive, and its bear case already sits at the current price Bear $707, base $1,209, bull $1,659 (WACC 12.5-14%, terminal g 2.5%). The base case starts from 25% growth off peak FCF of $58.96B. The reverse DCF implies only a 10.1% start growth, but on peak FCF.
  • Sell-side is uniformly bullish while the price is weak, so there is little variant perception to exploit 45 analysts, strong_buy, mean target $1,562 (+123%); stock -28% over 3m, -13.6% over 5d, below its 30-week MA (Stage 1/3).

Risks

  • Memory cycle turn: DRAM/NAND oversupply or pricing falls would send margins from 80% back toward the 22-40% seen in FY2024-25, cutting EPS by a large multiple
  • Capex and capacity response from competitors that ends the shortage
  • Customer concentration in AI/data center demand and possible order digestion
  • High beta (raw 2.4) means a drawdown in the broader market hits hard
  • Mechanical DCF extrapolates peak FCF, so reported values are overstated
⌕Accounting quality & events neutral · 55

MU (Micron) shows a very strong financial profile: Piotroski F-Score 9/9, Altman Z 11.97 (safe), net cash of $38.3B. The Beneish M-Score of -0.15 is above the -1.78 threshold, but it is mostly driven by explosive sales growth (SGI 3.56), not by cash-less profit (TATA is negative at -0.024). Verdict is WATCH: the flags look like a hypergrowth artifact, but receivables and officer changes deserve checks. Earnings on 2026-12-23 are the key event.

Key findings

  • Beneish M-Score flags 'investigate', but growth drives it M = -0.15 vs threshold -1.78; SGI 3.563, DSRI 1.246, TATA -0.024 (negative accruals = profit backed by cash). SGI alone adds ~3.18 to the score (0.892 x 3.563)
  • Receivables grew faster than revenue Receivables +343.85% vs revenue +256.33%; DSRI 1.246. Mild but worth a DSO check
  • Accruals ratio is high on the cash-flow version 71.7% vs the >20% investigate band. However, FCF $58.96B vs net margin 63.8% on $133.2B revenue gives FCF conversion 69%. The big investing outlay (capex) inflates this ratio in a growth build-out
  • Cash conversion improved sharply FCF conversion 69.0% in FY2026 vs 20.0% FY2025 and 16.0% FY2024
  • SBC and goodwill are not concerns SBC 1.0% of revenue (down from 3.3%); goodwill 0.6% of assets; diluted shares 1,143M vs 1,125M
  • Distress risk is negligible (Z applies, MU is not a bank) Altman Z 11.97 safe (>2.99); Z'' 10.27 safe (>2.60); current ratio 3.31; net debt/EBITDA -0.35; interest coverage 941x

Risks

  • Large expected earnings move (~7.6% average, up to 16%) on 2026-12-23; a tiny beat can still sell off at peak margins
  • Extreme growth and margin expansion are cyclical; reversal would hit profits and receivables
  • Receivables outgrowing revenue could signal looser terms or customer concentration
  • Insider Form 144 planned sales and 5.02 officer changes could be innocent but should be monitored
  • Position sizing: $50 risk per trade on a $10,000 account; a gap of ±16% can exceed stops
◍Macro, policy & credit bearish · 62

The macro backdrop is a headwind for MU. SPY is 4.16% below its 50-day, VIX is 24.85 in backwardation, and there are 8 distribution days in 25 sessions. The 10y yield is about 5.1% and CPI is 4.08% y/y. MU's sector (XLK) trails SPY by 6.59 pts over 3 months, and MU trails SPY by 24.05 pts. With a 1y beta of 3.43 (2.4 in the risk block) and 84.4% annual volatility, the stock magnifies any market stress, so risk should be reduced.

Key findings

  • Market regime is an uptrend under pressure with heavy institutional selling SPY -4.16% vs SMA50 but +0.07% vs SMA200; 8 distribution days in 25 sessions; SPY -5.01% in 1m
  • Volatility is in stress mode VIX 24.85, up 43.56% in 1m, above VIX3M 24.51 (backwardation); implied SPX daily move 1.57%
  • Breadth and growth are weaker than the index QQQ -8.15% 1m and -3.32% vs SMA200; IWM -3.01% vs SMA200; XLK -11.78% 1m
  • Rates are high and not easing, which compresses long-duration multiples 10y 5.07% (FRED 5.12%), 2y 4.83%, 3m 4.14%; 10y up 7.88% in 3m; DXY 103.79, +4.94% in 3m
  • Inflation is elevated while the Fed funds rate sits below it, limiting room to cut CPI 4.08% y/y vs Fed funds 3.88% (real policy rate about -0.2pp); unemployment 4.1%, down 0.3 over 12m
  • Credit is calm, which is a partial offset; it is not yet a warning HY spread 3.43pp, +0.14 in 1m; HYG/LQD ratio +0.02% (risk-on); curve 10y-3m +0.77pp (positive, no inversion)

Risks

  • High beta of 2.4-3.43 and 84.4% vol mean gaps can exceed a $50 risk budget unless the position is sized small
  • Further rise in the 10y above 5.1% could extend multiple compression for semis
  • Persistent CPI of about 4% could force a hawkish Fed, which would hurt growth names
  • VIX backwardation may deepen into a broader sell-off, and HY spreads could widen
  • Policy shocks to semis (export controls, tariffs, Taiwan tail risk)
⟋Technical analysis bearish · 72

MU is in a sharp correction inside a larger multi-year advance. Price is 44% below its 52-week high and below the 10/21 EMA and the 50/150/200 SMA, with only 4 of 8 Trend Template checks passed. Momentum and volume are weak, but RSI2 is at 8.8, so a short-term oversold bounce is possible. The best setup is a counter-trend bounce at most. There is no clean long setup, and the market regime is also under pressure.

Key findings

  • Trend Template fails and the stage is not Stage 2 4/8 checks passed; price is below the 50 SMA (-24.22%) and below the 200 SMA (-8.89%); Weinstein 'Stage 1/3 - basing or topping'
  • Price is below every key MA, and the short EMAs are stacked down Close 701.28 vs EMA10 752.77, EMA21 803.92, SMA50 925.46, SMA150 891.41, SMA200 769.72. The 200 SMA is still rising (+6.37% over 1 month), so the long-term backdrop is not yet broken.
  • Strong downtrend momentum ADX14 35.5 with -DI 36.4 vs +DI 15.0; MACD -60.12 below its signal -56.17; ROC20 -23.25%; 5d return -13.56%
  • Oversold, but RSI14 is in the downtrend range RSI14 36.7 (a 20-60 range is normal in downtrends); RSI2 8.8 (<10, but the rule requires close > 200 SMA, and the close is 8.89% below it); Stoch slow K 19.9
  • Volatility is extreme and the base is not constructive ATR14 57.56 = 8.21% of price; HV20 105.8%; pullback depths 22.48% -> 29.2% -> 52.31% (expanding), contracting_volatility false; 4-week range 52.31%
  • Volume shows distribution CMF20 -0.128; OBV 20d falling; up/down volume ratio 0.8; distribution days 6 vs accumulation days 6; last-bar RVOL 0.8 (no capitulation spike)

Risks

  • Violent relief rally: RSI2 8.8 and %B 0.2 could trigger a snap-back toward the EMA10 (752.77) or Kijun (820) against a short position
  • Daily moves of about 8% (ATR) make small stops hard to place; with a $50 risk budget, position sizes would be tiny
  • A break below 651 support could open a move toward 435.76
  • The 200 SMA is still rising and the 1y return is +190%, so a long-term uptrend resumption is possible if 651 holds and price reclaims the EMA21
⇄Positioning & sentiment neutral · 55

Positioning is mixed. Short interest is tiny (2.07% of float, 0.86 days to cover), so there is no squeeze fuel, and institutions are net adders. Against that, insiders have only sold, options are very expensive in absolute terms (ATM IV 75-79%), and put skew is steep after a 44% drawdown from the high. Flows are neutral to mildly contradicting the downtrend, and sentiment looks wary rather than euphoric or panicked.

Key findings

  • Short interest is very low, so there is no squeeze fuel and shorts are not driving the decline SI 2.07% of float, days to cover 0.86, -10.14% vs prior month, squeeze_risk low
  • Insiders are selling and not buying; weak signal on its own 0 open-market buys, 13 sales worth $246.3M in 180d, 0 distinct buyers
  • Institutions are net adders, though 13F data lags about 45 days and predates the recent 5d -13.56% drop Institutions hold 79.44%; 8 of the top 10 are adding (FMR +32.84%, Morgan Stanley +8.0%, State Street +2.09%); JPMorgan -13.17%
  • Tape-level volume shows mild distribution, which is consistent with the downtrend CMF20 -0.128, OBV 20d falling, up/down volume 0.8, distribution days 6 vs accumulation days 6, last volume 22.6M vs 50d average 28.2M
  • Options: the near-term expected move is large and the term structure is inverted, which signals event or fear pricing. IV is still below realized volatility. 5 DTE ATM IV 79.1%, straddle $56.8, expected move ±8.1% (range 644-758); 30 DTE IV 75.5% (±17.5%); IV/HV20 0.71 'cheap'; VIX 24.85 in backwardation
  • Put skew shows demand for downside protection, but call-side activity points to speculative upside interest. Unusual volume is concentrated in a thin weekly expiry, so it is a weak signal. 25d put-minus-call skew 14.7 pts (5 DTE) and 9.3 pts (30 DTE); put/call volume 0.53; put/call OI 0.76 (5 DTE) and 1.06 (30 DTE); 840 calls volume 1,867 vs OI 195; median ATM OI only 60

Risks

  • Crowded long positioning after a +190% 1-year run: institutions hold 79%, and an exit could be violent if the AI-memory narrative cracks
  • Insider selling of $246M with no buyers offers no support
  • Very high absolute IV and an inverted term structure imply wide, fast swings; the stock is 44% below its high with price below its 30-week MA
  • Bearish-bet headlines and steep put skew could fuel further downside hedging flows
  • Thin open interest in weekly options makes unusual-activity signals unreliable and fills costly
⚡Trading plans

MU is in a short-term downtrend (price 701.33 below VWAP 701.96, 4/8 Trend Template, 8 SPY distribution days, VIX backwardation). Intraday it is a possible range day with RVOL 1.3, so it is only marginally in play. It is 15:38 ET, with about 20 minutes left before the close. No new day trade is recommended today. There is no valid swing long, and a daily-Donchian system is flat. The trader has PDT restrictions on a $10k margin account, so day trades are scarce.

◇Options

MU is in a sharp downtrend (technical bearish 72, macro headwind, 5d -13.6%), but a short-term oversold bounce is possible. Fundamentals are neutral (price ~ fair value of ~$630). Options are cheap vs realized volatility (IV/HV20 0.71) with an inverted term structure. The trader's options risk budget is about $100 (1% of $10k) and $50 per trade, and every candidate with defined risk is either too large or has weak edge. Only the cheapest-risk structure that fits the bearish view and the budget is offered, and the rest are rejected.

⛨Risk management

Both proposed plans have hard violations in RISK_CHECKS (valid=false) and are rejected. The day short has reward:risk of 1.00 against a 1.5 minimum, and it would use a scarce PDT day trade on a stock with RVOL 1.3 that is not in play. The bear put spread has a max loss of $465 against a $100 options budget, which allows 0 contracts. MU's volatility is 84.4%, ATR is 8.21% and beta is 2.4, so gaps can exceed a $50 risk budget on a $10k account. Standing aside is the correct position today.

Risks

  • Gap and volatility: annual vol 84.4%, ATR14 8.21%, worst day -17.46%, 88 gaps over 3% in 1y. A single gap can exceed the $50 risk budget, because stops do not guarantee fills.
  • Market regime: SPY is below its 50-day with 8 distribution days, VIX is 24.85 in backwardation, and beta is 2.4 (3.43 on another window). A 5% SPY drop implies roughly -12% to -17% for MU.
  • Short squeeze or oversold bounce: squeeze risk is low (SI 2.07% of float, 0.86 days to cover), but RSI2 of 8.8 makes a sharp bounce toward 752-823 plausible. That is a risk to any short.
  • Earnings on 2026-12-23 are 35 days away (average move 7.6%, up to 16%). The last EPS beat was only 1.36%, so peak-cycle margin risk is real.
  • Accounting: the forensic verdict is WATCH. Beneish M-Score is -0.15, receivables grew 343.85% vs revenue 256.33%, and there were 6 Form 144 filings and two 5.02 officer changes. No hard red flag yet.

Key data

Price$701.28
Market cap$793.44B
1M / 1Y return-21.74% / +190.17%
vs 52-week high-44.10%
Trend stageStage 1/3 - basing or topping (price below flat 30-week MA)
Trend Template4/8
RSI (14) / ADX36.7 / 35.5
ATR % of price8.21%
Support651.00, 435.76
Resistance823.00, 929.59
P/E (trailing / forward)9.4 / 3.4
EV / EBITDA7.0
FCF yield7.43%
ROIC84.7%
Net debt / EBITDA-0.35
Street target (mean)$1,561.91
Next earnings2026-12-23
Avg earnings move7.60%
ATM implied vol79.1%
Options expected move8.10%
IV vs realizedcheap (IV below realized)
Short interest (float)2.07%
Market regimeuptrend under pressure (SPY below 50-day, above 200-day)
VIX / 10-yr yield24.85 / 5.07%

Figures are calculated from public market data at the time of the report and may be delayed or inaccurate.

Report details

Published
Prices and data as of
Data sourcesYahoo Finance · SEC EDGAR · FRED

Research methodology → · Disclaimer